Tandem Health Raises $100M to Build Europe’s AI Clinic
The AI scribe may only be the beginning.
Stockholm-based Tandem Health has raised €86.49 million, or about $100 million, in Series B funding as it attempts to expand from automated clinical documentation into a broader AI operating system for European healthcare.
The round was led by EQT's Scaleup Europe Fund, with participation from existing investors including Kinnevik, Northzone, Amino Collective and Visionaries. Tandem has now raised about $160 million in total funding.
That's substantial funding for a company founded in 2023.
It also reflects how quickly medical AI is moving beyond note-taking.
AI scribes solved an obvious problem
Doctors spend an enormous amount of time documenting care.
That made medical transcription one of generative AI's clearest early healthcare applications.
A system can listen to a consultation, summarize the interaction and prepare documentation without forcing the clinician to spend additional time typing notes.
Tandem started in that world.
Now it wants to do more.
Its product already supports clinicians before, during and after visits, including preparing patient summaries, assisting with clinical decisions and handling documentation and coding. The company says individual components have received Class IIa medical-device certification under European rules.
The ambition is increasingly to become infrastructure for the entire clinic.
Europe creates a very different AI market
Healthcare is difficult to scale globally because every country has its own medical systems, languages, workflows, reimbursement structures and regulations.
Europe makes that fragmentation especially visible.
A healthcare product that works in Sweden isn't automatically ready for Germany, France or Spain.
That complexity can slow expansion.
It can also become a competitive advantage for companies that solve it.
Tandem says it already supports more than 10,000 care organizations across Europe, while maintaining certifications covering areas including information security, quality management and country-specific healthcare requirements.
That gives it something a newly imported American AI product may not immediately have: regulatory and workflow infrastructure designed specifically around European healthcare.
The next step is an AI operating system
The phrase “AI assistant” is starting to feel too narrow for many enterprise AI companies.
They increasingly want to become operating systems.
For Tandem, that means moving beyond individual productivity features into patient flows and AI agents that can complete additional clinical tasks.
The company plans to use its new capital to expand across markets and grow its clinician-led development team, which already includes more than 75 in-house clinicians.
That's important.
Healthcare AI cannot simply optimize for technical benchmarks.
It has to fit real medical workflows and satisfy regulators and practitioners.
Investors are betting on vertical AI
Tandem's round fits one of the clearest venture themes of 2026.
General AI models may be increasingly commoditized.
Industry-specific workflows are not.
Healthcare companies need products designed around medical data and regulation.
Law firms need legal workflows.
Banks need financial compliance.
Construction companies need tools that understand physical projects.
Investors increasingly believe large companies can be created by taking foundation-model capability and wrapping it in deep industry expertise.
The economics are attractive if the AI actually saves time
Tandem says research involving its product found reductions in administrative time and stress among clinicians, alongside improvements in job satisfaction.
That is the metric health systems will care about.
AI in healthcare has no shortage of impressive demonstrations.
The harder question is whether it makes clinicians meaningfully more productive without creating new safety or administrative problems.
Products that can demonstrate measurable time savings have a much easier procurement story.
What happens next?
The most interesting healthcare AI companies may begin looking less like apps and more like infrastructure.
Tandem is betting that once an AI system handles documentation, adding coding, patient preparation, clinical support and eventually agentic workflows becomes the natural next step.
If that strategy works, the company won't just be selling doctors a better note-taking tool.
It will be trying to become the software layer through which an increasing portion of the clinic operates.
And that is a much bigger market.